Titre:
  • Efficacy and safety of MCLA-129, an anti-EGFR/c-MET bispecific antibody, in non-small-cell lung cancer (NSCLC) with c-METexon 14 skipping mutations ( MET ex14).
Auteur:Brandão, Mariana; Zugazagoitia, Jon; Dingemans, Anne Marie A.M.C.; Duruisseaux, Michaël; Parent, Pauline; Juan-Vidal, Oscar; Spira, Alexander I.; Vicier, Cécile; Zalcman, Gérard; Barasa, Ben; Yan, Chris; Doze, Petra; Joe, Andrew K.; Laus, Gianluca; Felip, Enriqueta
Informations sur la publication:Journal of clinical oncology, 42, 16_suppl, page (8583-8583)
Statut de publication:Publié, 2024-06
Sujet CREF:Cancérologie
Langue:Anglais
Identificateurs:urn:issn:0732-183X
info:doi/10.1200/JCO.2024.42.16_suppl.8583